The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
IgA Nephropathy
Abstract
IgA nephropathy is the most common form of primary glomerulonephritis in the world and is also the most common cause of end-stage renal disease in patients with primary glomerulopathy. This article discusses current views on the pathogenesis, pathophysiology, clinical course, and treatment of this important glomerular disease. Although clinical trials have suggested that therapies such as glucocorticoids, n–3 fatty acids, and angiotensin-converting–enzyme inhibitors are efficacious, more definitive treatment is being sought.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corticosteroids in IgA nephropathy: a randomised controlled trial
Pozzi, C., Bolasco, P., Fogazzi, G., Andrulli, S., Altieri, P., Ponticelli, C., & Locatelli, F. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03563-6 · Cited by 532
Predicting renal outcome in IgA nephropathy.
Radford, M. G., Donadio, J. V., Bergstralh, E. J., & Grande, J. P. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v82199 · Cited by 440
Self-citationA Controlled Trial of Fish Oil in IgA Nephropathy
Donadio, J. V., Bergstralh, E. J., Offord, K. P., Spencer, D. C., & Holley, K. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411033311804 · Cited by 408
Self-citationProteinuria as a modifiable risk factor for the progression of non-diabetic renal disease
Jafar, T. H., Stark, P. C., Schmid, C. H., Landa, M., Maschio, G., Marcantoni, C., De Jong, P. E., De Zeeuw, D., Shahinfar, S., Ruggenenti, P., et al. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0600031131.x · Cited by 377
Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG
Tomana, M., Matoušovic, K., Julian, B. A., Radl, J., Konecný, K., & Mestecky, J. (1997) · Kidney International · doi:10.1038/ki.1997.361 · Cited by 341
IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22–23
Gharavi, A. G., Yan, Y., Scolari, F., Schena, F. P., Frasca, G. M., Ghiggeri, G. M., Cooper, K., Amoroso, A., Viola, B. F., Battini, G. G., et al. (2000) · Nature Genetics · doi:10.1038/81677 · Cited by 332
Controlled Prospective Trial of Prednisolone and Cytotoxics in Progressive IgA Nephropathy
Ballardie, F. W., & Roberts, I. S. D. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131142 · Cited by 317
Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients
Allen, A. C., Bailey, E. M., Brenchley, P. E., Buck, K., Barratt, J., & Feehally, J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.060003969.x · Cited by 311
Galla, J. H. (1995) · Kidney International · doi:10.1038/ki.1995.50 · Cited by 301
Maisonneuve, P., Agodoa, L., Gellert, R., Stewart, J. H., Buccianti, G., Lowenfels, A. B., Wolfe, R. A., Jones, E., Disney, A. P. S., Briggs, D., et al. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70316-7 · Cited by 294
Cited by
Wyatt, R. J., & Julian, B. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1206793 · Cited by 1,222
Pathogenesis and Treatment of Chronic Kidney Disease: A Review of Our Recent Basic and Clinical Data
Tomino, Y. (2014) · Kidney and Blood Pressure Research · doi:10.1159/000368458 · Cited by 566
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy
Barbour, S. J., Coppo, R., Zhang, H., Liu, Z.-H., Suzuki, Y., Matsuzaki, K., Katafuchi, R., Er, L., Espino-Hernandez, G., Kim, S. J., et al. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.0600 · Cited by 478
Predicting the Risk for Dialysis or Death in IgA Nephropathy
Berthoux, F., Mohey, H., Laurent, B., Mariat, C., Afiani, A., & Thibaudin, L. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040355 · Cited by 361
Yu, X.-Q., Li, M., Zhang, H., Low, H.-Q., Wei, X., Wang, J.-Q., Sun, L.-D., Sim, K.-S., Li, Y., Foo, J.-N., et al. (2012) · Nature Genetics · doi:10.1038/ng.1047 · Cited by 312
Maes, B. D., Oyen, R., Claes, K., Evenepoel, P., Kuypers, D., Vanwalleghem, J., Damme, B. V., & Vanrenterghem, Y. F. C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00588.x · Cited by 269
Li, P. K.-T., Leung, C. B., Chow, K. M., Cheng, Y. L., Fung, S. K.-S., Mak, S. K., Tang, A. W.-C., Wong, T. Y.-H., Yung, C. Y., Yung, J. C.-U., et al. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.01.017 · Cited by 223
Corticosteroid therapy in IgA nephropathy
Lv, J., Xu, D., Perkovic, V., Ma, X., Johnson, D. W., Woodward, M., Levin, A., Zhang, H., & Wang, H. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011111112 · Cited by 190
Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy
Duan, Z.-Y., Cai, G.-Y., Bu, R., Lu, Y., Hou, K., & Chen, X.-M. (2016) · Scientific Reports · doi:10.1038/srep23498 · Cited by 61
Metadata
- Authors
- Donadio, J. V., & Grande, J. P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-09-05
- Volume
- 347
- Issue
- 10
- Pages
- 738-748
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4241655994
- Cited by
- 661
- References
- 48
- FWCI
- 13.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.